# Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome

> clinical trial · VERIFIED · 2025-12-02

Status: NOT_YET_RECRUITING · Sponsor: Fenix Innovation Group · Condition: RETT Syndrome With Proven MECP2 Mutation

- Company: Fenix Innovation Group
- Sector: rare disease
- Primary source: https://clinicaltrials.gov/study/NCT07257978

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.